Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers
Following the successes of monoclonal antibody immunotherapies (trastuzumab (Herceptin®) and rituximab (Rituxan®)) and the first approved cancer vaccine, Provenge® (sipuleucel-T), investigations into the immune system and how it can be modified by a tumor has become an exciting and promising new fie...
Main Authors: | Erica M. Pimenta, Betsy J. Barnes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/2/969 |
Similar Items
-
Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors
by: Daming Cai, et al.
Published: (2023-01-01) -
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes
by: Lilit Karapetyan, et al.
Published: (2023-06-01) -
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
by: Ching-Hung Hsieh, et al.
Published: (2022-01-01) -
Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer
by: Hao Yuan, et al.
Published: (2024-01-01) -
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
by: Sehhoon Park, et al.
Published: (2023-03-01)